Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.
Centre for Gastrointestinal Sciences, University of Manchester, Salford, UK.
Transl Stroke Res. 2018 Apr;9(2):120-129. doi: 10.1007/s12975-017-0548-0. Epub 2017 Aug 2.
Post-stroke dysphagia is common, associated with poor outcome and often requires non-oral feeding/fluids. The relationship between route of feeding and outcome, as well as treatment with glyceryl trinitrate (GTN), was studied prospectively. The Efficacy of Nitric Oxide in Stroke (ENOS) trial assessed transdermal GTN (5 mg versus none for 7 days) in 4011 patients with acute stroke and high blood pressure. Feeding route (oral = normal or soft diet; non-oral = nasogastric tube, percutaneous endoscopic gastrostomy tube, parenteral fluids, no fluids) was assessed at baseline and day 7. The primary outcome was the modified Rankin Scale (mRS) measured at day 90. At baseline, 1331 (33.2%) patients had non-oral feeding, were older, had more severe stroke and more were female, than 2680 (66.8%) patients with oral feeding. By day 7, 756 patients had improved from non-oral to oral feeding, and 119 had deteriorated. Non-oral feeding at baseline was associated with more impairment at day 7 (Scandinavian Stroke Scale 29.0 versus 43.7; 2p < 0.001), and worse mRS (4.0 versus 2.7; 2p < 0.001) and death (23.6 versus 6.8%; 2p = 0.014) at day 90. Although GTN did not modify route of feeding overall, randomisation ≤6 h of stroke was associated with a move to more oral feeding at day 7 (odds ratio = 0.61, 95% confidence intervals 0.38, 0.98; 2p = 0.040). As a proxy for dysphagia, non-oral feeding is present in 33% of patients with acute stroke and associated with more impairment, dependency and death. GTN moved feeding route towards oral intake if given very early after stroke. Clinical Trial Registration Clinical Trial Registration-URL: http://www.controlled-trials.com . Unique identifier: ISRCTN99414122.
脑卒中后吞咽困难很常见,与不良预后相关,常需进行非经口喂养/补液。本研究前瞻性地探讨了喂养途径与结局的关系,以及甘油三硝酸酯(GTN)的治疗作用。《卒中后一氧化氮疗效(ENOS)》试验评估了 4011 例急性卒中且伴高血压患者的经皮 GTN(5mg 组 vs. 7 天内无 GTN 组)。在基线和第 7 天评估喂养途径(经口=正常或软食;非经口=鼻胃管、经皮内镜下胃造口管、肠外补液、无补液)。主要结局为第 90 天改良 Rankin 量表(mRS)评分。基线时,1331 例(33.2%)患者为非经口喂养,这些患者较 2680 例(66.8%)经口喂养患者年龄更大、卒中更严重且女性更多。至第 7 天,756 例患者从非经口喂养转为经口喂养,119 例患者病情恶化。基线时非经口喂养与第 7 天的神经功能缺损更严重(斯堪的纳维亚卒中量表评分 29.0 分 vs. 43.7 分;2p<0.001)、mRS 评分更差(4.0 分 vs. 2.7 分;2p<0.001)和第 90 天死亡率更高(23.6% vs. 6.8%;2p=0.014)相关。尽管 GTN 总体上未改变喂养途径,但卒中后 6 小时内随机分组与第 7 天经口喂养比例增加相关(比值比 0.61,95%置信区间 0.38,0.98;2p=0.040)。非经口喂养作为吞咽困难的替代指标,见于 33%的急性卒中患者,与更严重的神经功能缺损、依赖和死亡相关。如果在卒中后非常早期给予 GTN,可使喂养途径向经口摄入转变。
临床研究注册 临床研究注册网址:http://www.controlled-trials.com。唯一识别码:ISRCTN99414122。